Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

976.4000 1.65 (0.17%)

NSE Jun 26, 2025 10:21 AM

26.27% Fall from 52W High

Volume: 135.6K

Zydus Lifesciences Ltd.

02 Jun 2025

976.40

0.17%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives tentative approval from the USFDA for Rifaximin Tablets 550 mg

More from Zydus Lifesciences Ltd.

Recommended

Market opens higher, Texmaco Rail bags an order worth Rs 535 crore from Camalco SA

Trendlyne Marketwatch | 26 Jun 2025, 10:01AM

Five stocks to buy from analysts this week - June 25, 2025

The Baseline | 25 Jun 2025, 11:20AM

Earnings Call Transcript - Cadila Healthcare